Literature DB >> 3535602

Selective venous sampling for gastrin to localize gastrinomas. A prospective assessment.

J A Cherner, J L Doppman, J A Norton, D L Miller, A G Krudy, J P Raufman, M J Collen, P N Maton, J D Gardner, R T Jensen.   

Abstract

In 27 consecutive patients with Zollinger-Ellison syndrome, we prospectively evaluated the ability of selective venous sampling for gastrin to localize gastrinomas, then compared the results with those from imaging studies and with findings at surgery. All patients had a gastrin gradient, but in only 20 patients was it significant. Neither the magnitude of the gastrin gradient nor its presence or absence correlated with the frequency with which gastrinoma was found at surgery. A gastrinoma was found at surgery in 15 patients, of whom 12 had positive imaging studies, 11 had a significant gastrin gradient, 14 had both tests positive, and 1 had both tests negative. A gastrinoma was not found at surgery in 12 patients, of whom 8 had a significant gradient and none had a positive imaging study. Gastrin sampling has equal sensitivity with imaging studies in localizing gastrinoma, but imaging studies have higher positive and negative predictive values and higher specificity. Thus, selective venous sampling for gastrin is much less useful in localizing gastrinoma than has been suggested and should not be routinely done preoperatively in patients with Zollinger-Ellison syndrome.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3535602     DOI: 10.7326/0003-4819-105-6-841

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  31 in total

1.  Intraoperative ultrasonographic localization of islet cell tumors. A prospective comparison to palpation.

Authors:  J A Norton; D T Cromack; T H Shawker; J L Doppman; R Comi; P Gorden; P N Maton; J D Gardner; R T Jensen
Journal:  Ann Surg       Date:  1988-02       Impact factor: 12.969

Review 2.  Unresolved surgical issues in the management of patients with Zollinger-Ellison syndrome.

Authors:  J A Norton; R T Jensen
Journal:  World J Surg       Date:  1991 Jan-Feb       Impact factor: 3.352

3.  Surgery increases survival in patients with gastrinoma.

Authors:  Jeffrey A Norton; Douglas L Fraker; H R Alexander; Fathia Gibril; David J Liewehr; David J Venzon; Robert T Jensen
Journal:  Ann Surg       Date:  2006-09       Impact factor: 12.969

Review 4.  Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies.

Authors:  Tetsuhide Ito; Lingaku Lee; Robert T Jensen
Journal:  Expert Opin Pharmacother       Date:  2016-09-23       Impact factor: 3.889

5.  Treatment of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1: Some Clarity But Continued Controversy.

Authors:  Robert T Jensen; Jeffrey A Norton
Journal:  Pancreas       Date:  2017 May/Jun       Impact factor: 3.327

Review 6.  Gastrinomas: Medical or Surgical Treatment.

Authors:  Jeffrey A Norton; Deshka S Foster; Tetsuhide Ito; Robert T Jensen
Journal:  Endocrinol Metab Clin North Am       Date:  2018-09       Impact factor: 4.741

7.  Does the use of routine duodenotomy (DUODX) affect rate of cure, development of liver metastases, or survival in patients with Zollinger-Ellison syndrome?

Authors:  Jeffrey A Norton; H Richard Alexander; Douglas L Fraker; David J Venzon; Fathia Gibril; Robert T Jensen
Journal:  Ann Surg       Date:  2004-05       Impact factor: 12.969

Review 8.  Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances.

Authors:  Tetsuhide Ito; Hisato Igarashi; Robert T Jensen
Journal:  Best Pract Res Clin Gastroenterol       Date:  2012-12       Impact factor: 3.043

9.  The Zollinger-Ellison syndrome. A collective surgical experience.

Authors:  D R Farley; J A van Heerden; C S Grant; L J Miller; D M Ilstrup
Journal:  Ann Surg       Date:  1992-06       Impact factor: 12.969

10.  Gastrinomas: a 42-year experience.

Authors:  E L Kaplan; K Horvath; A Udekwu; F Straus; C Schark; D J Ferguson; D B Skinner
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.